Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Immutep Stock Price, Quotes and Forecasts | NASDAQ:IMMP | Benzinga
Explore Immutep stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for IMMP.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Immutep (IMMP) stock?
You can purchase shares of Immutep (NASDAQ:IMMP) through any online brokerage.
Who are Immutep (IMMP) competitors?
Other companies in Immutep’s space includes: Humacyte (NASDAQ:HUMA), Anika Therapeutics (NASDAQ:ANIK), Olema Pharmaceuticals (NASDAQ:OLMA), Ironwood Pharmaceuticals (NASDAQ:IRWD) and Monte Rosa Therapeutics (NASDAQ:GLUE).
What is the forecast, or price target, for Immutep (IMMP) stock?
Immutep has a consensus price target of $9.00.
What is the current price for Immutep (IMMP)?
The stock price for Immutep (NASDAQ: IMMP) is $1.37 last updated April 7, 2025 at 4:08 PM EDT.
Does Immutep (IMMP) pay a dividend?
There are no upcoming dividends for Immutep.
When is Immutep (NASDAQ:IMMP) reporting earnings?
Immutep’s H1 earnings are confirmed for Monday, April 21, 2025.
Is Immutep (IMMP) going to split?
There is no upcoming split for Immutep.
What sector and industry does Immutep (IMMP) operate in?
Immutep is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.